Swedish Orphan Biovitrum (Sobi) has agreed a merger with CTI BioPharma, a US biopharmaceutical company focused on blood-related cancers and rare diseases. Through a...
19.11.2019
- French drugmaker Servier has acquired blood cancer treatment Pixuvri from US-based CTI BioPharma for an undisclosed sum. Pixuvri is a treatment for adults with multiply relapsed or...